Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

MLA

Beelen, Dietrich Wilhelm, et al. Treosulfan or Busulfan plus Fludarabine as Conditioning Treatment before Allogeneic Haemopoietic Stem Cell Transplantation for Older Patients with Acute Myeloid Leukaemia or Myelodysplastic Syndrome (MC-FludT.14/L): A Randomised, Non-Inferiority, Phase 3 Trial. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1364934969&authtype=sso&custid=ns315887.

APA

Beelen, D. W., Trenschel, R., Stelljes, M., Groth, C., Masszi, T., Remenyi, P., Wagner-Drouet, E.-M., Hauptrock, B., Dreger, P., Luft, T., Bethge, W., Vogel, W., Ciceri, F., Peccatori, J., Stoelzel, F., Schetelig, J., Junghanss, C., Grosse-Thie, C., Michallet, M., … Markiewicz, M. (2020). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Chicago

Beelen, Dietrich Wilhelm, Rudolf Trenschel, Matthias Stelljes, Christoph Groth, Tamas Masszi, Peter Remenyi, Eva-Maria Wagner-Drouet, et al. 2020. “Treosulfan or Busulfan plus Fludarabine as Conditioning Treatment before Allogeneic Haemopoietic Stem Cell Transplantation for Older Patients with Acute Myeloid Leukaemia or Myelodysplastic Syndrome (MC-FludT.14/L): A Randomised, Non-Inferiority, Phase 3 Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1364934969&authtype=sso&custid=ns315887.